Publication

Development of tumour selective and endoprotease-activated anticancer therapeutics.

Gill, Jason H.
; 
Publication Date
2008
End of Embargo
Supervisor
Keywords
MMP, Prodrug, Anticancer therapeutics, Antitumor activity, Endoprotease
Rights
Peer-Reviewed
No
Open Access status
closedAccess
Accepted for publication
Institution
Department
Awarded
Embargo end date
Collections
Life Sciences Publications
Show all metadata
Additional title
Abstract
URI
http://hdl.handle.net/10454/4566
Version
No full-text in the repository
Citation
Gill, J. H. and Loadman, Paul M. (2008). Development of tumour selective and endoprotease-activated anticancer therapeutics. In: Edwards, D., Hoyer-Hansen, G., Blasi, F. and Sloane, B. F. (Eds.). The Cancer Degradome: Proteases and Cancer Biology. London: Springer. ISBN: 978-0-387-69056-8. Chapter 40.
Link to publisher’s version
Link to published version
Link to Version of Record
https://doi.org/10.1007/978-0-387-69057-5
Type
Book chapter
Qualification name
Notes